Pulmonary Damage Biomarkers for Risk of Rheumatoid Arthritis–Associated Interstitial Lung Disease: Enabling Early Detection and Risk Stratification
Pierre‐Antoine Juge,
Paul F. Dellaripa,
Jeffrey A. Sparks
Abstract:Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) has garnered increasing attention because of reports of higher-than-expected prevalence with persistent excess mortality, despite the availability of antifibrotics as novel therapeutic options. [1][2][3][4] Although antifibrotics have only modest efficacy, emerging therapeutic options have bolstered efforts for risk stratification, early detection, and identifying risk factors for progression of RA-ILD. Chest high-resolution computed tomography… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.